The Structural Basis of Disease

The structural basis of disease refers to understanding how changes in the 3D structures of biomolecules—such as proteins, enzymes, or nucleic acids—lead to the onset and progression of diseases. Mutations, misfolding, or abnormal interactions at the molecular level can disrupt normal biological functions and cause conditions like cancer, neurodegenerative disorders, and genetic diseases. By studying these structural changes, scientists can identify disease mechanisms, discover potential drug targets, and design more effective, structure-based therapies. This approach is crucial for developing precision medicine, as it links molecular abnormalities to clinical outcomes, enabling more accurate diagnosis and targeted treatment.

 

    Related Conference of The Structural Basis of Disease

    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    A Coruna, Spain

    The Structural Basis of Disease Conference Speakers